未登录

S

Strelnikov, V. V.

research centre for medical genetics

H指数:0

被引数:0

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Pathology of Methylation, Demethylation, and Methylated DNA Binding Machinery

甲基化、去甲基化及甲基化DNA结合机制的病理学

Molecular Biology

IF1.2

2026-02-010

PRE

Virtual amplicons for methylation-sensitive restriction enzyme quantitative PCR (MSRE-qPCR) derived from genome-wide DNA methylation sequencing: Application to prediction of breast cancer neoadjuvant chemotherapy response

ANNALS OF ONCOLOGY

IF65.4

2021-09-010

OAAI

Cyclophosphamide influence on survival probability of breast cancer patients depending on leukotriene receptor LTB4R gene expression level

ANNALS OF ONCOLOGY

IF65.4

2020-10-010

OAAI

Development of DNA methylation markers panels for neoadjuvant chemotherapy response prediction in triple-negative breast cancer

ANNALS OF ONCOLOGY

IF65.4

2020-10-010

OAAI

IRF4 gene promoter methylation predicts efficacy of luminal B breast tumours neoadjuvant chemotherapy

ANNALS OF ONCOLOGY

IF65.4

2020-09-010

OAAI

A seven-gene methylation markers panel: An epigenetic predictor of neoadjuvant chemotherapy sensitivity in triple-negative breast cancer

ANNALS OF ONCOLOGY

IF65.4

2019-11-010

OAAI

Leukotriene B4 receptors abnormal gene expression is associated with either shorter or longer survival in breast cancer patients depending on the intrinsic tumour molecular subtype

ANNALS OF ONCOLOGY

IF65.4

2019-11-011

OAAI

Leukotriene B4 receptors as a therapeutic target for triple-negative breast cancer

ANNALS OF ONCOLOGY

IF65.4

2018-09-011

OAAI

Analysis of changes in the markers of DNA methylation in the process of complex treatment in acute myeloid leukemia in children

ANNALS OF ONCOLOGY

IF65.4

2018-09-010

OAAI

Epigenomics paves a new way to assess potential toxicity and chemotherapeutic response of breast tumours to 5-fluorouracil

ANNALS OF ONCOLOGY

IF65.4

2018-09-011

OAAI

Mutations in TSC1/TSC2 genes are prevalent in sporadic renal angiomyolipoma and insulinoma tumors, supporting their responsiveness to mTOR inhibitors

ANNALS OF ONCOLOGY

IF65.4

2018-09-012

OAAI